Literature DB >> 20080967

Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands.

Lola Fernández-Messina1, Omodele Ashiru, Philippe Boutet, Sonia Agüera-González, Jeremy N Skepper, Hugh T Reyburn, Mar Valés-Gómez.   

Abstract

Tumor cells release NKG2D ligands to evade NKG2D-mediated immune surveillance. The purpose of our investigation was to explore the cellular mechanisms of release used by various members of the ULBP family. Using biochemical and cellular approaches in both transfectant systems and tumor cell lines, this paper shows that ULBP1, ULBP2, and ULBP3 are released from cells with different kinetics and by distinct mechanisms. Whereas ULBP2 is mainly shed by metalloproteases, ULBP3 is abundantly released as part of membrane vesicles known as exosomes. Interestingly, exosomal ULBP3 protein is much more potent for down-modulation of the NKG2D receptor than soluble ULBP2 protein. This is the first report showing functionally relevant differences in the biochemistry of the three members of the ULBP family and confirms that in depth study of the biochemical features of individual NKG2D ligands will be necessary to understand and manipulate the biology of these proteins for therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080967      PMCID: PMC2838276          DOI: 10.1074/jbc.M109.045906

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  The biogenesis and functions of exosomes.

Authors:  Willem Stoorvogel; Monique J Kleijmeer; Hans J Geuze; Graça Raposo
Journal:  Traffic       Date:  2002-05       Impact factor: 6.215

2.  A novel secreted tumor antigen with a glycosylphosphatidylinositol-anchored structure ubiquitously expressed in human cancers.

Authors:  H Onda; S Ohkubo; Y Shintani; K Ogi; K Kikuchi; H Tanaka; K Yamamoto; I Tsuji; Y Ishibashi; T Yamada; C Kitada; N Suzuki; H Sawada; O Nishimura; M Fujino
Journal:  Biochem Biophys Res Commun       Date:  2001-07-13       Impact factor: 3.575

3.  Brief residence at the plasma membrane of the MHC class I-related chain B is due to clathrin-mediated cholesterol-dependent endocytosis and shedding.

Authors:  Sonia Agüera-González; Philippe Boutet; Hugh T Reyburn; Mar Valés-Gómez
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

4.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

Authors:  D Cosman; J Müllberg; C L Sutherland; W Chin; R Armitage; W Fanslow; M Kubin; N J Chalupny
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

5.  A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3.

Authors:  Mirjana Radosavljevic; Benoît Cuillerier; Michael J Wilson; Oliver Clément; Sophie Wicker; Susan Gilfillan; Stephan Beck; John Trowsdale; Seiamak Bahram
Journal:  Genomics       Date:  2002-01       Impact factor: 5.736

6.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.

Authors:  Veronika Groh; Jennifer Wu; Cassian Yee; Thomas Spies
Journal:  Nature       Date:  2002-10-17       Impact factor: 49.962

7.  Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells.

Authors:  Roberta Castriconi; Claudia Cantoni; Mariella Della Chiesa; Massimo Vitale; Emanuela Marcenaro; Romana Conte; Roberto Biassoni; Cristina Bottino; Lorenzo Moretta; Alessandro Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

Review 8.  NKG2D ligands in tumor immunity.

Authors:  N Nausch; A Cerwenka
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

9.  Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid.

Authors:  Masahisa Jinushi; Tetsuo Takehara; Tomohide Tatsumi; Tatsuya Kanto; Veronika Groh; Thomas Spies; Ritsuko Kimura; Takuya Miyagi; Kiyoshi Mochizuki; Yutaka Sasaki; Norio Hayashi
Journal:  Int J Cancer       Date:  2003-04-10       Impact factor: 7.396

Review 10.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Authors:  A Moretta; C Bottino; M Vitale; D Pende; C Cantoni; M C Mingari; R Biassoni; L Moretta
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

View more
  73 in total

1.  Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.

Authors:  A Baragaño Raneros; V Martín-Palanco; A F Fernandez; R M Rodriguez; M F Fraga; C Lopez-Larrea; B Suarez-Alvarez
Journal:  Genes Immun       Date:  2014-11-13       Impact factor: 2.676

2.  An NKG2D-mediated human lymphoid stress surveillance response with high interindividual variation.

Authors:  Seema Shafi; Pierre Vantourout; Graham Wallace; Ayman Antoun; Robert Vaughan; Miles Stanford; Adrian Hayday
Journal:  Sci Transl Med       Date:  2011-11-30       Impact factor: 17.956

3.  A short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation.

Authors:  Lola Fernández-Messina; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Immunol Cell Biol       Date:  2016-01-06       Impact factor: 5.126

Review 4.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

5.  Transfer of the human NKG2D ligands UL16 binding proteins (ULBP) 1-3 is related to lytic granule release and leads to ligand retransfer and killing of ULBP-recipient natural killer cells.

Authors:  Sheila López-Cobo; Gema Romera-Cárdenas; Eva M García-Cuesta; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Immunology       Date:  2015-06-25       Impact factor: 7.397

Review 6.  NKG2D Receptor and Its Ligands in Host Defense.

Authors:  Lewis L Lanier
Journal:  Cancer Immunol Res       Date:  2015-06       Impact factor: 11.151

Review 7.  Recognition of tumors by the innate immune system and natural killer cells.

Authors:  Assaf Marcus; Benjamin G Gowen; Thornton W Thompson; Alexandre Iannello; Michele Ardolino; Weiwen Deng; Lin Wang; Nataliya Shifrin; David H Raulet
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 8.  Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

Authors:  Annie A Wu; Virginia Drake; Huai-Shiuan Huang; ShihChi Chiu; Lei Zheng
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

Review 9.  Transfer of extracellular vesicles during immune cell-cell interactions.

Authors:  Cristina Gutiérrez-Vázquez; Carolina Villarroya-Beltri; María Mittelbrunn; Francisco Sánchez-Madrid
Journal:  Immunol Rev       Date:  2013-01       Impact factor: 12.988

Review 10.  Regulation of ligands for the NKG2D activating receptor.

Authors:  David H Raulet; Stephan Gasser; Benjamin G Gowen; Weiwen Deng; Heiyoun Jung
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.